PetrovaNLBanatwallaRHuntKF, et al.Onset of an active charcot foot in a person with longstanding type 1 diabetes and normal vibration perception threshold-A case report. Int J Low Extrem Wounds. 2023 Mar 30:15347346231166550. Online ahead of print.
4.
WukichDKRaspovicKMSuderNC. Patients with diabetic foot disease fear major lower-extremity amputation more than death. Foot Ankle Spec. 2018;11(1):17-21.
5.
PapanasNMaltezosEEdmondsM. The diabetic foot: A plea for the elementary?Acta Diabetol. 2006;43(4):152-153.
6.
TsatsarisGRajamand EkbergNFallTCatrinaSB. Prevalence of charcot foot in subjects with diabetes: A nationwide cohort study. Diabetes Care. 2023;46(12):e217-e218.
7.
SvendsenOLRabeOCWinther-JensenMAllinKH. How common is the rare charcot foot in patients with diabetes?Diabetes Care. 2021;44(4):e62-e63.
8.
DiacogiorgisDPerrinBMKingsleyMIC. Factors impacting the evidence-based assessment, diagnosis and management of acute charcot neuroarthropathy: A systematic review. J Foot Ankle Res. 2021;14(1):26.
9.
WukichDKSchaperNCGoodayC, et al.Guidelines on the diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus (IWGDF 2023). Diabetes Metab Res Rev. 2024;40(3):e3646.
10.
ChantelauEAGrutznerG. Is the eichenholtz classification still valid for the diabetic charcot foot?Swiss Med Wkly. 2014 Apr 24;144:w13948.
11.
AhluwaliaRBilalAPetrovaN, et al.The role of bone scintigraphy with SPECT/CT in the characterization and early diagnosis of stage 0 charcot neuroarthropathy. J Clin Med. 2020 Dec 21;9(12):4123.
12.
RaspovicKMSchaperNCGoodayC, et al.Diagnosis and treatment of active charcot neuro-osteoarthropathy in persons with diabetes mellitus: A systematic review. Diabetes Metab Res Rev. 2024;40(3):e3653.
13.
AhluwaliaRArmstrongDGPetrovaNPapanasNEdmondsM. Stage 0 charcot neuroarthropathy in the diabetic foot: An emerging narrow window of opportunity?Int J Low Extrem Wounds. 2022;21(4):374-376.
14.
ChantelauEA. Start treatment early to avoid charcot foot deformity. Br Med J.2012;344:e2765.
15.
SchougJKatzmanPFagherKLöndahlM. Charcot foot offloading in stage 0 is associated with shorter total contact cast treatment and lower risk of recurrence and reconstructive surgery: A pilot study. Diabetes Care. 2024;47(2):252-258.
16.
BlathraEAnastasiouIAEleftheriadouIPapanasNTentolourisN. Charcot osteoarthropathy: A comprehensive analysis of recent research on novel biomarkers for early detection. Int J Low Extrem Wounds. 2025 Mar 25:15347346251328436. Online ahead of print.
17.
RebelosESiafarikasCTentolourisNJudeEB. Charcot foot: An update on diagnosis, treatment, and areas of uncertainty. Int J Low Extrem Wounds. 2024 May 8:15347346241253451. Online ahead of print.
18.
RebelosEAnastasiouIATentolourisAPapanasNJudeE. What is new on diabetic neuropathy? Insights from the 2023 ADA and EASD conferences. Int J Low Extrem Wounds. 2024 Feb 28:15347346241233938. Online ahead of print.
19.
ZhangYWangQLiuPYangXLiangJZhaoH. Metabolites and charcot foot: A comprehensive analysis through Mendelian randomization. Int J Low Extrem Wounds. 2025 Feb 24:15347346251321524. Online ahead of print.
20.
ShehajADopkeKMParachaAW, et al.Cost-effective modeling for management options in charcot neuroarthropathy. Int J Low Extrem Wounds. 2025 Feb 3:15347346251313652. Online ahead of print.
